Novo Nordisk buys manufacturing power as it seeks to ramp up Wegovy
Novo Nordisk is acquiring three manufacturing sites from Catalent as it seeks to keep up with patient demand for weight-loss drug Wegovy.
Full Article
Novo Nordisk buys manufacturing power as it seeks to ramp up Wegovy
Washington Post
0 shares
1 views
You might like
Related news coverage
Latest Weight-Loss Drug Faces Shortages
Latest Weight-Loss Drug , Faces Shortages .
The United States Food and Drug Administration
(FDA) says that high demand..
Wibbitz Top Stories